Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
China National Seed Group Co. Ltd. currently manages a patent portfolio within the Biotechnology & Pharmaceuticals technology area. The data shows 1 pending office action across the entire portfolio. This single action represents the current active engagement with the patent office for this entity, indicating a focused prosecution effort.
The prosecution is highly concentrated, involving 1 distinct examiner and 1 distinct art unit. This indicates that the company's intellectual property is being evaluated within a specific technical niche by a single official. Such a narrow examination footprint means that the immediate patenting success for the portfolio depends on the interpretation of one individual within one administrative unit.
IBRAHIM, MEDINA AHMED is identified as the busiest examiner for this company, with 1 busiest examiner pending office action. Because this examiner holds the 1 pending office action, the near-term outcomes for the company are directly tied to this individual's review. Practitioners should focus on the specific tendencies of IBRAHIM, MEDINA AHMED to advance the Biotechnology & Pharmaceuticals filings.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| IBRAHIM, MEDINA AHMED | 1 | 87.4% | +12.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18911788 | SEMI-DOMINANT MOLECULAR MARKER RELATED TO MAIZE DWARF AND APPLICATION THEREOF | IBRAHIM, MEDINA AHMED | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18911788 | SEMI-DOMINANT MOLECULAR MARKER RELATED TO MAIZE DWARF AND APPLICATION THEREOF | IBRAHIM, MEDINA AHMED | — |
| Art Unit | Apps |
|---|---|
| 1662 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18911788 | SEMI-DOMINANT MOLECULAR MARKER RELATED TO MAIZE DWARF AND APPLICATION THEREOF | IBRAHIM, MEDINA AHMED | 1662 | §112 | Final Rejection | — | Pending | Oct 10, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial